HSDT
Solana Co
NASDAQ · Healthcare · Medical - Devices · US
$2.76
+20.52%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$2.35
From 52W high−88.56%
Volume1.08M
Market cap$166.87M
P/E (TTM)—
P/S (TTM)13.8x
Div yield—
Key dataSep 18, 2026
Open
$2.35
From 52W high
−88.56%
Volume
1.08M
Market cap
$166.87M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.2x
P/E (TTM)
—
RSI (14)
69.1
MomentumView details →
1D Return
+20.52%
YTD Return
−8.13%
SummaryUpdated Jun 1, 2026
Helius Medical Technologies, Inc. (NASDAQ:HSDT) is a neurotechnology company founded in 2014 and headquartered in Newtown, Pennsylvania. The company specializes in developing non-invasive medical devices for treating neurological conditions, with its flagship product being the Portable Neuromodulation Stimulator (PoNS). Since going public in 2014, Helius has focused on commercializing its neurostimulation technology for patients suffering from balance and gait deficits caused by multiple sclerosis, traumatic brain injury, and stroke.
Similar companies
Latest newsMore news →